Concentration: Listed as mg/ml (e.g., "5 mg/ml")
Semaglutide needs to remain refrigerated to maintain its potency
It is estimated that 25% of the global population has NAFLD, a number projected to continue to rise, and as it does, it is expected that more of these cases will progress to end-stage disease states requiring liver transplantation
That means symptoms involving the stomach and intestines, such as nausea, vomiting, constipation, or diarrhea
The protocol was approved by an independent ethics committee (South CentralBerkshire B Research Ethics Committee)
Semaglutide belongs to a class of medications called glucagon-like peptide-1 (GLP-1) agonists